Analysis of bacterial communities during Clostridium difficile infection in the mouse

Infection and Immunity

Volumn 83, Issue 11, 2015, Pages 4383-4391

  Semenyuk, Ekaterina G ^a   Poroyko, Valeriy A ^b   Johnston, Pehga F ^a,c   Jones, Sara E ^a   Knight, Katherine L ^a   Gerding, Dale N ^c   Driks, Adam ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ANAEROSTIPES; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM; BACTERIUM IDENTIFICATION; BACTEROIDACEAE; BACTEROIDETES; BIOFILM; BLAUTIA; CECUM; CLOSTRIDIUM DIFFICILE INFECTION; COLON; CONTROLLED STUDY; DNA SEQUENCE; ENTEROBACTERIACEAE; ERYSIPELOTRICHACEAE; FIRMICUTES; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GENE SEQUENCE; HOST; LACHNOSPIRACEAE; LACTOBACILLUS; MICROBIAL COMMUNITY; MICROBIAL POPULATION DYNAMICS; MOUSE; MOUSE MODEL; NONHUMAN; PARABACTEROIDES; PORPHYROMONADACEAE; PRIORITY JOURNAL; PROTEUS; SEQUENCE ANALYSIS; ANIMAL; C57BL MOUSE; CLASSIFICATION; CLOSTRIDIUM INFECTION; DISEASE MODEL; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY;

ANIMALS; BACTERIA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; HUMANS; MICE; MICE, INBRED C57BL; MICROBIOTA;

EID: 84947592107     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00145-15     Document Type: Article

References (46)

1. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536. http://dx.doi.org/10.1038/nrmicro2164.
2. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18:247-263. http://dx.doi.org/10.1128/CMR.18.2.247-263.2005.
3. Thomas V, Rochet V, Boureau H, Ekstrand C, Bulteau S, Dore J, Bourlioux P. 2002. Molecular characterization and spatial analysis of a simplified gut microbiota displaying colonization resistance against Clostridium difficile. Microb Ecol Health Dis 14:203-210. http://dx.doi.org/10.1080/08910600310002082.
4. Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. 2013. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 51:2884-2892. http://dx.doi.org/10.1128/JCM.00845-13.
5. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G. 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8:e1002995. http://dx.doi.org/10.1371/journal.ppat.1002995.
6. Sorg JA, Sonenshein AL. 2008. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190:2505-2512. http://dx.doi.org/10.1128/JB.01765-07.
7. Rea MC, Alemayehu D, Casey PG, O'Connor PM, Lawlor PG, Walsh M, Shanahan F, Kiely B, Ross RP, Hill C. 2014. Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology 160:439-445. http://dx.doi.org/10.1099/mic.0.068767-0.
8. Kamada N, Seo SU, Chen GY, Nunez G. 2013. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321-335. http://dx.doi.org/10.1038/nri3430.
9. Wilson KH, Perini F. 1988. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 56: 2610-2614.
10. Pham TA, Lawley TD. 2014. Emerging insights on intestinal dysbiosis during bacterial infections. Curr Opin Microbiol 17:67-74. http://dx.doi.org/10.1016/j.mib.2013.12.002.
11. Britton RA, Young VB. 2012. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20:313-319. http://dx.doi.org/10.1016/j.tim.2012.04.001.
12. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, Sonnenburg JL. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96-99. http://dx.doi.org/10.1038/nature12503.
13. Theriot CM, Koenigsknecht MJ, Carlson PE, Jr, Hatton GE, Nelson AM, Li B, Huffnagle GB, Li JZ, Young VB. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5:3114.
14. Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL. 2014. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe 16:770-777. http://dx.doi.org/10.1016/j.chom.2014.11.003.
15. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. 2011. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2:145-158. http://dx.doi.org/10.4161/gmic.2.3.16333.
16. Buckley AM, Spencer J, Candlish D, Irvine JJ, Douce GR. 2011. Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J Med Microbiol 60:1174-1180. http://dx.doi.org/10.1099/jmm.0.028514-0.
17. Johnston PF, Gerding DN, Knight KL. 2014. Protection from Clostridium difficile infection in CD4 T cell-and polymeric immunoglobulin receptor-deficient mice. Infect Immun 82:522-531.
18. Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. 1997. Histochemistry of the surface mucous gel layer of the human colon. Gut 40:782-789. http://dx.doi.org/10.1136/gut.40.6.782.
19. Bloedt K, Riecker M, Poppert S, Wellinghausen N. 2009. Evaluation of new selective culture media and a rapid fluorescence in situ hybridization assay for identification of Clostridium difficile from stool samples. J Med Microbiol 58:874-877. http://dx.doi.org/10.1099/jmm.0.009811-0.
20. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA.1990. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56:1919-1925.
21. Daims H, Bruhl A, Amann R, Schleifer KH, Wagner M. 1999. The domain-specific probe EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a more comprehensive probe set. Syst Appl Microbiol 22:434-444. http://dx.doi.org/10.1016/S0723-2020(99)80053-8.
22. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y.2008. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 135:568-579. http://dx.doi.org/10.1053/j.gastro.2008.04.017.
23. Salzman NH, de Jong H, Paterson Y, Harmsen HJM, Welling GW, Bos NA. 2002. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 148: 3651-3660. http://dx.doi.org/10.1099/00221287-148-11-3651.
24. Friedrich U, Van Langenhove H, Altendorf K, Lipski A. 2003. Microbial community and physicochemical analysis of an industrial waste gas biofilter and design of 16S rRNA-targeting oligonucleotide probes. Environ Microbiol 5:183-201. http://dx.doi.org/10.1046/j.1462-2920.2003.00397.x.
25. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. 1996. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacterbacteroides in the natural environment. Microbiology 142(Pt 5):1097-1106. http://dx.doi.org/10.1099/13500872-142-5-1097.
26. McInnes P, Cutting M. 2010. Manual of procedures for Human Microbiome Project core microbiome sampling protocol A: HMP protocol no. 07-001, version no. 12.0. NIH, Bethesda, MD. http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetPdf.cgi?id=phd003190.2.
27. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, Gormley N, Gilbert JA, Smith G, Knight R. 2012. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6:1621-1624. http://dx.doi.org/10.1038/ismej.2012.8.
28. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 79:5112-5120. http://dx.doi.org/10.1128/AEM.01043-13.
29. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
30. White JR, Nagarajan N, Pop M. 2009. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 5:e1000352. http://dx.doi.org/10.1371/journal.pcbi.1000352.
31. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP. 2008. A mouse model of Clostridium difficileassociated disease. Gastroenterology 135:1984-1992. http://dx.doi.org/10.1053/j.gastro.2008.09.002.
32. Johansson ME, Larsson JM, Hansson GC. 2011. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108: 4659-4665. http://dx.doi.org/10.1073/pnas.1006451107.
33. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP. 2005. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 11:1131-1140. http://dx.doi.org/10.3748/wjg.v11.i8.1131.
34. Good IJ. 1953. The Population frequencies of species and the estimation of population parameters. Biometrika 40:237-264.
35. Simpson EH. 1949. Measurement of diversity. Nature 163:688. http://dx.doi.org/10.1038/163688a0.
36. Neumann H, Vieth M, Raithel M, Mudter J, Kiesslich R, Neurath MF.2010. Confocal laser endomicroscopy for the in vivo detection of intraepithelial neoplasia in Peutz-Jeghers polyps. Endoscopy 42(Suppl 2):E139-E140. http://dx.doi.org/10.1055/s-0029-1244052.
37. Goulding D, Thompson H, Emerson J, Fairweather NF, Dougan G, Douce GR. 2009. Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1. Infect Immun 77:5478-5485. http://dx.doi.org/10.1128/IAI.00551-09.
38. Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 197:435-438. http://dx.doi.org/10.1086/525047.
39. Koenigsknecht MJ, Theriot CM, Bergin IL, Schumacher CA, Schloss PD, Young VB. 2015. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract. Infect Immun 83:934-941. http://dx.doi.org/10.1128/IAI.02768-14.
40. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, Ubeda C, Xavier J, Pamer EG. 2012. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80:62-73. http://dx.doi.org/10.1128/IAI.05496-11.
41. Baines SD, Crowther GS, Todhunter SL, Freeman J, Chilton CH, Fawley WN, Wilcox MH. 2013. Mixed infection by Clostridium difficile in an in vitro model of the human gut. J Antimicrob Chemother 68:1139-1143. http://dx.doi.org/10.1093/jac/dks529.
42. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J. 2010. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1:254-268. http://dx.doi.org/10.4161/gmic.1.4.12778.
43. Probert HM, Gibson GR. 2002. Bacterial biofilms in the human gastrointestinal tract. Curr Issues Intest Microbiol 3:23-27.
44. Macfarlane S, Woodmansey EJ, Macfarlane GT. 2005. Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system. Appl Environ Microbiol 71:7483-7492. http://dx.doi.org/10.1128/AEM.71.11.7483-7492.2005.
45. Semenyuk EG, Laning ML, Foley J, Johnston PF, Knight KL, Gerding D, Driks A. 2014. Spore formation and toxin production in Clostridium difficile biofilms. PLoS One 9:e87757. http://dx.doi.org/10.1371/journal.pone.0087757.
46. Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M. 2013. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 195:545-555. http://dx.doi.org/10.1128/JB.01980-12.